Share This:
https://ntp.niehs.nih.gov/go/17417

TDMS Study 99034-01 Pathology Tables

NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03
Route: GAVAGE                                                                                                     Time: 14:49:58

                                                         FINAL #1 MICE




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  71-43-2

       Lock Date:  10/15/01

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
    Terminal Sacrifice                                15           15           15           15           15                        
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Small, Duodenum                          (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic Active                                                            2 (13%)                               
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                                                        1 (7%)       1 (7%)                   
      Inflammation, Chronic                           10 (67%)      6 (40%)      6 (40%)      4 (27%)     11 (73%)                  
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
      Erosion                                                                                 1 (7%)                                
      Hyperplasia                                      1 (7%)                                                                       
      Inflammation, Chronic                                                      3 (20%)                                            
   Stomach, Glandular                                 (15)         (15)         (15)         (15)         (15)                      
      Mineralization                                                                                       1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
      Myocardium, Inflammation, Chronic                                                                    1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Pituitary Gland                                    (15)         (15)         (15)         (15)         (15)                      
      Infiltration Cellular, Lymphoid                  1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Clitoral Gland                                     (1)                                                                           
      Pigmentation                                     1 (100%)                                                                     
   Ovary                                              (14)         (15)         (15)         (15)         (15)                      
      Angiectasis                                                                                          1 (7%)                   
      Cyst                                             1 (7%)                                 2 (13%)      2 (13%)                  
   Uterus                                             (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic Active                                                                         1 (7%)                   
      Inflammation, Suppurative                                                  1 (7%)       1 (7%)       1 (7%)                   
      Endometrium, Hyperplasia, Cystic                12 (80%)     15 (100%)    15 (100%)    15 (100%)    14 (93%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (13)         (11)         (11)         (12)         (13)                      
      Lumbar, Hyperplasia, Lymphoid                                                                        1 (8%)                   
      Lumbar, Pigmentation                                                                                 1 (8%)                   
      Mediastinal, Atrophy                                                       2 (18%)      4 (33%)      2 (15%)                  
   Lymph Node, Mandibular                             (14)         (15)         (15)         (15)         (15)                      
      Atrophy                                                       1 (7%)       2 (13%)      4 (27%)                               
      Hyperplasia, Lymphoid                            1 (7%)       4 (27%)      2 (13%)      5 (33%)      3 (20%)                  
      Infiltration Cellular, Polymorphonuclear         1 (7%)                                              2 (13%)                  
   Lymph Node, Mesenteric                             (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                                       2 (13%)      3 (20%)      8 (53%)      6 (40%)                  
      Hyperplasia, Lymphoid                                                                                1 (7%)                   
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                 5 (33%)      5 (33%)      2 (13%)      3 (20%)      7 (47%)                  
      Infiltration Cellular, Lymphocyte                1 (7%)                                                                       
      Lymphoid Follicle, Atrophy                                    1 (7%)       1 (7%)                    1 (7%)                   
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia, Atypical                                         1 (7%)       1 (7%)       1 (7%)       1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia                                                                                          2 (13%)                  
   Skin                                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Granulomatous                      1 (7%)                    1 (7%)                                             
      Inflammation, Suppurative                                                               1 (7%)       1 (7%)                   
      Pigmentation                                                  1 (7%)       8 (53%)     15 (100%)    15 (100%)                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)         (15)         (15)         (15)         (15)                      
      Fibrosis                                                                   1 (7%)       1 (7%)       1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic Active                     2 (13%)      2 (13%)                                2 (13%)                  
      Alveolar Epithelium, Hyperplasia, Focal          1 (7%)                                              3 (20%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
      Casts Protein                                    5 (33%)      4 (27%)      5 (33%)      8 (53%)      7 (47%)                  
      Infiltration Cellular, Lymphoid                  1 (7%)                                                                       
      Infiltration Cellular, Lymphocyte                1 (7%)                                                                       
      Nephropathy                                      3 (20%)                   1 (7%)       2 (13%)      1 (7%)                   
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                                                                     1                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                15           15           15           15           14                        
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                            3 (20%)      6 (40%)      1 (7%)       3 (20%)      1 (7%)                   
   Salivary Glands                                                                           (1)          (1)                       
      Submandibular Gland, Atrophy                                                                         1 (100%)                 
      Submandibular Gland, Inflammation, Chronic                                              1 (100%)                              
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
      Erosion                                                                                              1 (7%)                   
      Hyperplasia                                      1 (7%)                                              3 (20%)                  
      Inflammation, Acute                                                                     1 (7%)                                
   Stomach, Glandular                                 (15)         (15)         (15)         (15)         (15)                      
      Mineralization                                                             1 (7%)                                             
      Glands, Cyst                                                               1 (7%)       1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
      Myocardium, Inflammation, Chronic                             1 (7%)       1 (7%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (15)         (15)         (15)         (15)         (15)                      
      Granuloma Sperm                                                                                      1 (7%)                   
      Unilateral, Hypospermia                          1 (7%)                                                                       
   Testes                                             (15)         (15)         (15)         (15)         (15)                      
      Germinal Epithelium, Atrophy                                                            1 (7%)                                
      Germinal Epithelium, Syncytial Alteration                                               1 (7%)       1 (7%)                   
      Rete Testes, Inflammation, Granulomatous         1 (7%)                                                                       
      Unilateral, Germinal Epithelium, Atrophy         1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                                                                10 (67%)     12 (80%)                  
      Pigmentation, Hemosiderin                        1 (7%)      13 (87%)     13 (87%)     15 (100%)    14 (93%)                  
   Lymph Node                                         (11)         (11)         (12)         (9)          (7)                       
      Mediastinal, Atrophy                                                       2 (17%)      6 (67%)      6 (86%)                  
   Lymph Node, Mandibular                             (15)         (15)         (15)         (14)         (14)                      
      Atrophy                                                                                 6 (43%)     11 (79%)                  
      Hyperplasia, Lymphoid                            2 (13%)      1 (7%)       1 (7%)                                             
      Infiltration Cellular, Polymorphonuclear                                                1 (7%)       1 (7%)                   
   Lymph Node, Mesenteric                             (15)         (15)         (14)         (15)         (15)                      
      Atrophy                                          1 (7%)       2 (13%)      2 (14%)     13 (87%)     13 (87%)                  
      Infiltration Cellular, Polymorphonuclear                                                             1 (7%)                   
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                              1 (7%)                    2 (13%)      8 (53%)                  
      Lymphoid Follicle, Atrophy                                                             15 (100%)    14 (93%)                  
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                                                                 7 (47%)     13 (87%)                  
      Mineralization                                                                                       1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (15)         (15)         (15)         (15)         (15)                      
      Pigmentation                                                 15 (100%)    15 (100%)    15 (100%)    14 (93%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)         (15)         (15)         (15)         (15)                      
      Pigmentation, Hemosiderin                                                  1 (7%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic Active                     2 (13%)                   1 (7%)       3 (20%)      5 (33%)                  
      Alveolar Epithelium, Hyperplasia, Focal                                    1 (7%)                                             
      Bronchiole, Hyperplasia, Focal                                             1 (7%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
      Casts Protein                                    1 (7%)                    2 (13%)      1 (7%)       2 (13%)                  
      Nephropathy                                      1 (7%)       1 (7%)                    2 (13%)      4 (27%)                  
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------